Evidence map›Paper›PMID 28427383›Full record

ReviewCardiovascular diabetology2017

Is ischemia the only factor predicting cardiovascular outcomes in all diabetes mellitus patients?

Mark W Kennedy, Enrico Fabris, Harry Suryapranata, Elvin Kedhi

Open access · goldAbstract readReview
In one paragraph

Review in Cardiovascular diabetology, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers.

0numbers the graph read from it
0cells of the map it votes in
21citing papers in PubMed
4.0field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

21 citing papers in PubMed, 26 citations in OpenAlex.

  1. Long-term outcomes of patients with normal fractional flow reserve and thin-cap fibroatheroma.EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology · 2023
    Trial
  2. Article
  3. Ten-year predictors of major adverse cardiovascular events in patients without angina.South African family practice : official journal of the South African Academy of Family Practice/Primary Care · 2023
    Article
  4. Review
  5. Review
  6. Article
  7. Diabetic heart disease: A clinical update.World journal of diabetes · 2021
    Review
  8. Article
  9. Review
  10. Review
  11. Article
  12. Article
  13. Article
  14. Article
  15. Observational
  16. Review
  17. Article
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 1 country.

Mark W KennedyIsala Hartcentrum, Docter van Heesweg 2, Zwolle, The Netherlands.
Enrico FabrisIsala Hartcentrum, Docter van Heesweg 2, Zwolle, The Netherlands.
Harry SuryapranataIsala Hartcentrum, Docter van Heesweg 2, Zwolle, The Netherlands.
Elvin KedhiIsala Hartcentrum, Docter van Heesweg 2, Zwolle, The Netherlands. e.kedhi@isala.nl.
Diagram (Netherlands) · NLIsala · NL

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Diabetes mellitus (DM) is associated with an excess in cardiovascular morbidity and mortality, and is characterized by increased rates of coronary artery disease. Furthermore, once atherosclerosis is established, this is associated with an increased extent, complexity and a more rapid progression than seen in non-DM patients. Ischemia is the single most important predictor of future hard cardiac events and ischemia correction remains the cornerstone of current revascularization strategies. However recent data suggests that, in DM patients, coronary atherosclerosis despite the absence of ischemia, detected by either invasive or non-invasive methods, may not be associated with the same low risk of future cardiac events as seen in non-DM patients. This review seeks to examine the current evidence supporting an ischemia driven revascularization strategy, and to challenge the notion that ischemia is the only clinically relevant factor in the prediction of cardiovascular outcomes in all-comer DM patients. Specifically, we examine whether in DM patients certain characteristics beyond ischemia, such as microvascular disease, coronary atherosclerosis burden, progression and plaque composition, may need to be considered for a more refined risk stratification in these high-risk patients.

Indexed as

Coronary Artery DiseaseDiabetes MellitusFractional Flow Reserve, MyocardialHumansMyocardial IschemiaPredictive Value of TestsRisk FactorsTreatment OutcomeDiabetes mellitusFractional flow reserveIschemiaMajor adverse cardiac event

Identifiers

PMID28427383
PMCPMC5397766
OpenAlexW2606820355

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.